You are here: Home » PTI Stories » National » News
Business Standard

Laurus Labs gets nod to make malaria tablets

Press Trust of India  |  Hyderabad 

: City-based drug-maker Laurus Labs Ltd Monday received final approval from the United States (US FDA) for tablets 200 mg meant to treat a certain type of

The tablet is also used, usually with other medications, to treat (lupus, rheumatoid arthritis), a press release said here.

is therapeutically equivalent to plaquenil tablets 200 mg of Concordia Pharmaceuticals, Inc, the release said.

Also, Laurus Labs received a tentative approval for an ANDA (abbreviated new drug application) for Abacavir, Dolutegravir and tablets from the US FDA, it said.

The products would be commercialised from Laurus's manufacturing site in Visakhapatnam, it added.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, March 11 2019. 19:17 IST